Literature DB >> 31685956

End of the road for direct oral anticoagulants in thrombotic APS?

Joanna Collison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31685956     DOI： 10.1038/s41584-019-0335-2

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.

Authors:  Josep Ordi-Ros; Luis Sáez-Comet; Mercedes Pérez-Conesa; Xavier Vidal; Antoni Riera-Mestre; Antoni Castro-Salomó; Jordi Cuquet-Pedragosa; Vera Ortiz-Santamaria; Montserrat Mauri-Plana; Cristina Solé; Josefina Cortés-Hernández
Journal:  Ann Intern Med       Date:  2019-10-15       Impact factor: 25.391
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.